Vident Advisory LLC Trims Stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Vident Advisory LLC lowered its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 41.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 20,885 shares of the real estate investment trust's stock after selling 14,712 shares during the period. Vident Advisory LLC's holdings in Sabra Health Care REIT were worth $362,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new position in shares of Sabra Health Care REIT in the fourth quarter valued at about $48,950,000. Northern Trust Corp raised its stake in Sabra Health Care REIT by 27.7% during the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock valued at $72,214,000 after purchasing an additional 905,466 shares during the period. Thrivent Financial for Lutherans raised its stake in Sabra Health Care REIT by 95.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,816,217 shares of the real estate investment trust's stock valued at $31,457,000 after purchasing an additional 888,908 shares during the period. Wellington Management Group LLP lifted its holdings in Sabra Health Care REIT by 33.7% in the 4th quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after purchasing an additional 808,207 shares in the last quarter. Finally, Nuveen Asset Management LLC boosted its stake in Sabra Health Care REIT by 30.8% in the 4th quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after purchasing an additional 795,902 shares during the period. Institutional investors own 99.40% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on SBRA. Truist Financial lifted their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research report on Tuesday, March 18th. Scotiabank raised their target price on shares of Sabra Health Care REIT from $18.00 to $19.00 and gave the company a "sector perform" rating in a research note on Monday, May 12th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $19.50.

Insider Activity at Sabra Health Care REIT

In other news, Director Michael J. Foster sold 11,000 shares of Sabra Health Care REIT stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the transaction, the director now owns 64,725 shares in the company, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.20% of the stock is owned by insiders.

Sabra Health Care REIT Stock Performance

Shares of SBRA remained flat at $17.48 during mid-day trading on Monday. The stock had a trading volume of 1,572,883 shares, compared to its average volume of 2,219,515. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The stock has a market cap of $4.16 billion, a P/E ratio of 32.98, a PEG ratio of 1.97 and a beta of 0.88. Sabra Health Care REIT, Inc. has a twelve month low of $13.87 and a twelve month high of $20.03. The stock has a 50-day simple moving average of $17.54 and a 200-day simple moving average of $17.31.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.01. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company had revenue of $183.54 million for the quarter, compared to analysts' expectations of $180.23 million. During the same quarter in the previous year, the business posted $0.35 earnings per share. Sabra Health Care REIT's quarterly revenue was up 10.1% on a year-over-year basis. On average, sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.86%. The ex-dividend date of this dividend was Friday, May 16th. Sabra Health Care REIT's dividend payout ratio is 203.39%.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.